COHERUS cracking $21 will unleash major bullish potential

COHERUS BIOSCIENCES Inc., CHRS, is a bioscience company that has not yet not benefited from the sector's outperformance despite significantly improving financials and the business becoming profitable. When the stock price cracks the $21 level it will unlock a significant bullish potential.